Cargando…
Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications
[Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherica...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280960/ https://www.ncbi.nlm.nih.gov/pubmed/35847343 http://dx.doi.org/10.1021/acsomega.2c02316 |
_version_ | 1784746769335189504 |
---|---|
author | Hesabizadeh, Tina Hicks, Evan Medina Cruz, David Bourdo, Shawn E. Watanabe, Fumiya Bonney, Marvin Nichols, John Webster, Thomas J. Guisbiers, Grégory |
author_facet | Hesabizadeh, Tina Hicks, Evan Medina Cruz, David Bourdo, Shawn E. Watanabe, Fumiya Bonney, Marvin Nichols, John Webster, Thomas J. Guisbiers, Grégory |
author_sort | Hesabizadeh, Tina |
collection | PubMed |
description | [Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherical with a diameter of around 70 nm. The energy band gap of those nanoparticles was determined to be around 5.2 eV. Moreover, TeO(2) NPs displayed a dose-dependent antibacterial effect against antibiotic-resistant bacteria such as multidrug-resistant Escherichia coli (MDR E. coli) and methicillin-resistant Staphylococcus aureus (MR S. aureus). The “naked” nature of the nanoparticle surface helped to eradicate the antibiotic-resistant bacteria at a very low concentration, with IC50 values of ∼4.3 ± 0.9 and 3.7 ± 0.2 ppm for MDR E. coli and MR S. aureus, respectively, after just 8 h of culture. Further, the IC50 values of the naked TeO(2) NPs against melanoma (skin cancer) and healthy fibroblasts were 1.6 ± 0.7 and 5.5 ± 0.2 ppm, respectively, for up to 72 h. Finally, to understand these optimal antibacterial and anticancer properties of the TeO(2) NPs, the reactive oxygen species generated by the nanoparticles were measured. In summary, the present in vitro results demonstrate much promise for the presently prepared TeO(2) NPs and they should be studied for a wide range of safe antibacterial and anticancer applications. |
format | Online Article Text |
id | pubmed-9280960 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-92809602022-07-15 Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications Hesabizadeh, Tina Hicks, Evan Medina Cruz, David Bourdo, Shawn E. Watanabe, Fumiya Bonney, Marvin Nichols, John Webster, Thomas J. Guisbiers, Grégory ACS Omega [Image: see text] Chalcogenide nanoparticles have become a very active field of research for their optoelectronic and biological properties. This article shows the production of tellurium dioxide nanoparticles (TeO(2) NPs) by pulsed laser ablation in liquids. The produced nanoparticles were spherical with a diameter of around 70 nm. The energy band gap of those nanoparticles was determined to be around 5.2 eV. Moreover, TeO(2) NPs displayed a dose-dependent antibacterial effect against antibiotic-resistant bacteria such as multidrug-resistant Escherichia coli (MDR E. coli) and methicillin-resistant Staphylococcus aureus (MR S. aureus). The “naked” nature of the nanoparticle surface helped to eradicate the antibiotic-resistant bacteria at a very low concentration, with IC50 values of ∼4.3 ± 0.9 and 3.7 ± 0.2 ppm for MDR E. coli and MR S. aureus, respectively, after just 8 h of culture. Further, the IC50 values of the naked TeO(2) NPs against melanoma (skin cancer) and healthy fibroblasts were 1.6 ± 0.7 and 5.5 ± 0.2 ppm, respectively, for up to 72 h. Finally, to understand these optimal antibacterial and anticancer properties of the TeO(2) NPs, the reactive oxygen species generated by the nanoparticles were measured. In summary, the present in vitro results demonstrate much promise for the presently prepared TeO(2) NPs and they should be studied for a wide range of safe antibacterial and anticancer applications. American Chemical Society 2022-06-30 /pmc/articles/PMC9280960/ /pubmed/35847343 http://dx.doi.org/10.1021/acsomega.2c02316 Text en © 2022 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Hesabizadeh, Tina Hicks, Evan Medina Cruz, David Bourdo, Shawn E. Watanabe, Fumiya Bonney, Marvin Nichols, John Webster, Thomas J. Guisbiers, Grégory Synthesis of “Naked” TeO(2) Nanoparticles for Biomedical Applications |
title | Synthesis of “Naked” TeO(2) Nanoparticles
for Biomedical Applications |
title_full | Synthesis of “Naked” TeO(2) Nanoparticles
for Biomedical Applications |
title_fullStr | Synthesis of “Naked” TeO(2) Nanoparticles
for Biomedical Applications |
title_full_unstemmed | Synthesis of “Naked” TeO(2) Nanoparticles
for Biomedical Applications |
title_short | Synthesis of “Naked” TeO(2) Nanoparticles
for Biomedical Applications |
title_sort | synthesis of “naked” teo(2) nanoparticles
for biomedical applications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280960/ https://www.ncbi.nlm.nih.gov/pubmed/35847343 http://dx.doi.org/10.1021/acsomega.2c02316 |
work_keys_str_mv | AT hesabizadehtina synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT hicksevan synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT medinacruzdavid synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT bourdoshawne synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT watanabefumiya synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT bonneymarvin synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT nicholsjohn synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT websterthomasj synthesisofnakedteo2nanoparticlesforbiomedicalapplications AT guisbiersgregory synthesisofnakedteo2nanoparticlesforbiomedicalapplications |